Subesh Williams
Director/Board Member bei GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Profil
Subesh Ronald Williams is currently a Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd.
and a Director at Galvani Bioelectronics Ltd.
Previously, he worked as a Senior Vice President-Corporate Development at GSK Plc, a Manager at PricewaterhouseCoopers Pvt Ltd., and as the Chief Financial Officer at ViiV.
Healthcare BV from 2009 to 2013.
Aktive Positionen von Subesh Williams
Unternehmen | Position | Beginn |
---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Director/Board Member | 07.04.2017 |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The private company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | Director/Board Member | 16.11.2016 |
Ehemalige bekannte Positionen von Subesh Williams
Unternehmen | Position | Ende |
---|---|---|
ViiV Healthcare BV
ViiV Healthcare BV Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare BV is a Dutch company that manufactures and distributes pharmaceutical products. The private company is based in Amersfoort, Netherlands. | Director of Finance/CFO | 01.01.2013 |
PricewaterhouseCoopers Pvt Ltd.
PricewaterhouseCoopers Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Pvt Ltd. provides accounting services. It offers services such as consulting, deals, risk advisory services, forensic services, accounting advisory, tax, and regulatory services. The company was incorporated on March 26, 1983 and is headquartered in Gurgaon, India. | Corporate Officer/Principal | - |
GSK PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
PricewaterhouseCoopers Pvt Ltd.
PricewaterhouseCoopers Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Pvt Ltd. provides accounting services. It offers services such as consulting, deals, risk advisory services, forensic services, accounting advisory, tax, and regulatory services. The company was incorporated on March 26, 1983 and is headquartered in Gurgaon, India. | Commercial Services |
ViiV Healthcare BV
ViiV Healthcare BV Pharmaceuticals: MajorHealth Technology Part of GSK Plc, ViiV Healthcare BV is a Dutch company that manufactures and distributes pharmaceutical products. The private company is based in Amersfoort, Netherlands. | Health Technology |
Galvani Bioelectronics Ltd.
Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The private company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | Health Technology |